Pascarella Giuseppe, Ruggiero Alessandro, Garo Maria L, Strumia Alessandro, DI Folco Marta, Papa Mario V, Giacinto Omar, Lusini Mario, Costa Fabio, Mattei Alessia, Schiavoni Lorenzo, Cataldo Rita, Chello Massimo, Agrò Felice E, Carassiti Massimiliano
Operative Research Unit of Anesthesia and Intensive Care, Campus Bio-Medico University Hospital, Rome, Italy.
Research Unit of Anesthesia and Intensive Care, Department of Medicine, Campus Bio-Medico University, Rome, Italy.
Minerva Anestesiol. 2024 Jul-Aug;90(7-8):662-671. doi: 10.23736/S0375-9393.24.18054-6.
Spinal anesthesia is a common anesthetic technique for lower limb and abdominal surgery. Despite its efficacy, its use is limited because of its duration and potential severe side effects, especially in high-risk patients undergoing major surgery. Adjuvants such as dexamethasone offer the potential to prolong the anesthetic effect and reduce the need for local anesthetics while reducing the incidence of serious adverse events. The purpose of this systematic review is to evaluate the efficacy of dexamethasone as an intrathecal adjuvant in prolonging anesthetic duration, delaying pain onset, and minimizing adverse events (PROSPERO registration: CRD42022350218).
We included randomized controlled trials conducted in adult patients undergoing spinal anesthesia for lower limb or abdominal surgery and comparing the performance of dexamethasone with alternative spinal treatments. A comprehensive systematic search was conducted on PubMed/MEDLINE, Scopus, CINAHL, EMBASE, CENTRAL, and Cochrane Library from February to June 2023 without language restriction. Risk of bias was assessed using the Cochrane Risk of Bias Tool (RoB2).
Ten studies, nine of which were at high risk of bias, were included (N.=685 patients). Overall, intrathecal dexamethasone was associated with a longer duration of sensory block, improvement in the duration or extent of postoperative analgesia, and significant shortening of block onset. The role of dexamethasone in prolonging motor block was not clear. The incidence of adverse events was low. Intrathecal dexamethasone has been shown to be a potentially valuable adjuvant to prolong the duration of sensory block and improve postoperative analgesia without increasing adverse events.
Given the wide heterogeneity of methodological approaches, further investigation is needed. Considering the limitations of the included studies and awaiting more conclusive evidence, the prudent use of dexamethasone could be recommended in those specific situations where general anesthesia or higher local anesthetics should be avoided.
脊髓麻醉是下肢和腹部手术常用的麻醉技术。尽管其效果良好,但由于其持续时间和潜在的严重副作用,其应用受到限制,尤其是在接受大手术的高危患者中。地塞米松等佐剂有可能延长麻醉效果,减少局部麻醉剂的使用,同时降低严重不良事件的发生率。本系统评价的目的是评估地塞米松作为鞘内佐剂在延长麻醉持续时间、延迟疼痛发作和减少不良事件方面的疗效(国际前瞻性系统评价注册库登记号:CRD42022350218)。
我们纳入了在接受下肢或腹部手术脊髓麻醉的成年患者中进行的随机对照试验,比较地塞米松与其他脊髓治疗方法的效果。2023年2月至6月,我们在PubMed/MEDLINE、Scopus、CINAHL、EMBASE、CENTRAL和Cochrane图书馆进行了全面的系统检索,不受语言限制。使用Cochrane偏倚风险工具(RoB2)评估偏倚风险。
纳入了10项研究,其中9项存在高偏倚风险(N=685例患者)。总体而言,鞘内地塞米松与感觉阻滞持续时间延长、术后镇痛持续时间或程度改善以及阻滞起效时间显著缩短相关。地塞米松在延长运动阻滞方面的作用尚不清楚。不良事件发生率较低。鞘内地塞米松已被证明是一种潜在有价值的佐剂,可延长感觉阻滞持续时间并改善术后镇痛,而不会增加不良事件。
鉴于方法学方法存在广泛的异质性,需要进一步研究。考虑到纳入研究的局限性并等待更确凿的证据,在应避免全身麻醉或使用更高剂量局部麻醉剂的特定情况下,可谨慎推荐使用地塞米松。